| |
Speakers
Aaron Bell, Ph.D.,
is a fifth year postdoctoral Research Associate in the department
of Pathology. Dr. Bell did his graduate work at the University of
Pittsburgh School of Medicine and received his PhD in Cellular and
Molecular Pathology in 1999 for his work with transgenic mouse
models of Hepatocyte Growth Factor gene regulation and function.
During his postdoctoral appointment he received two consecutive
Pathology Research Training Grants starting in 2000 and was
awarded an NIH National Research Service Award in 2001 for his
ongoing work with transcriptional regulation of hepatocyte growth,
regeneration and differentiation. Dr. Bell also completed a
Pittsburgh Health Sciences Fellowship awarded by the JHF/CORO
center for civic leadership and is actively involved in the
University of Pittsburgh Postdoctoral Association as well as the
Pathology Research Training Program.
R. Kevin Grigsby, D.S.W.,
is Vice Dean for Faculty and Administrative Affairs and Professor
in the Department of Neural and Behavioral Sciences at Penn State
College of Medicine in Hershey, Pennsylvania. Prior to being
appointed to his current position, he served as Vice-Dean for
Administration and Research in the School of Medicine at the
Medical College of Georgia, where he was also Professor of
Psychiatry and Health Behavior. Dr. Grigsby has an extensive
history of program planning, implementation, and evaluation in the
area of innovative home and community based health and mental
health services. His practice experience has been primarily in
under served rural and inner city areas. Areas of practice
expertise include children at imminent risk of out-of-home
placement, perinatal intervention with substance abusing women,
children and adolescents in shelter care, home-based services to
parents and children with HIV related illnesses, and the use of
advanced telecommunications technology in health services
delivery. His research interests include evaluating innovative
service delivery via advanced telecommunications technology and
the culture-bound syndrome of kaolin-specific pica. During the
past five years, the focus of Dr. Grigsby’s work has shifted to
organizational development in academic health centers. He has been
an advocate for supporting post-doctoral fellows within his own
institution, regionally, and nationally.
Joan
M. Lakoski, Ph.D.,
is the assistant vice chancellor for Academic Career Development
at the University of Pittsburgh Health Science Schools, founding
and executive director of the Office of Academic Career
Development, and professor of Pharmacology at the University of
Pittsburgh School of Medicine. She graduated from Mount Holyoke
College, received a PhD in Pharmacology from the University of
Iowa, and completed postdoctoral training in the Department of
Psychiatry at the Yale University School of Medicine. Dr. Lakoski
has held faculty positions at the University of Texas Medical
Branch in Galveston and the Penn State College of Medicine,
including interim chair of the Department of Pharmacology at Penn
State, and maintains an active federally funded research program
in the neuropharmacology of aging. She has been the recipient of
an NIH Research Career Development Award, a NARSAD Independent
Investigator Award, an Administrative Fellowship at The
Pennsylvania State University and was a Fellow of the Committee on
Institutional Cooperation Academic Leadership Program. Currently,
she serves as Chair of the Ethics Advisory Committee of the
Endocrine Society, as a member of the AAMC Faculty Affairs Program
Planning Committee, as Chair of the ASPET Committee on Women in
Pharmacology, as Secretary of the International Union of
Pharmacology Committee on Teaching, and is an AAMC Womens Liaison
Officer for the University of Pittsburgh School of Medicine. Her
administrative responsibilities include development and oversight
of comprehensive career development services for professional
students, postdoctoral fellows, residents, clinical fellows and
faculty across the Health Science Schools at the University of
Pittsburgh (Dental Medicine, Health and Rehabilitation Sciences,
Medicine, Nursing, Pharmacy, and Public Health).
Arthur S. Levine, M.D.,
joined the University of Pittsburgh in November 1998 as Senior
Vice Chancellor for the Health Sciences and Dean of the School of
Medicine. Previously, Dr. Levine spent his entire professional
career at the National Institutes of Health, having joined the NIH
as a Clinical Associate in the National Cancer Institute (NCI) in
1967. He became a Senior Investigator in 1970 and Chief of the
NCI's Pediatric Oncology Branch in 1975. From 1982 to 1998, Dr.
Levine was the Scientific Director of the National Institute of
Child Health and Human Development (NICHD). Throughout his career,
Dr. Levine has also been engaged in molecular biologic research.
Levine and his colleagues carried out the first physical and
genetic mapping of SV40, a mammalian tumor virus. Levine, who has
authored or co-authored more than 240 scientific publications, has
chaired many national and international scientific meetings, has
been elected to membership in a number of the leading research
societies, and has held visiting professorships at many
universities here and abroad. He has served on the editorial
boards of four scientific journals and was Editor-in-Chief of The
New Biologist, a journal of cellular and molecular biology. In
addition to having presented many scientific seminars, lectures,
and grand rounds world wide, Dr. Levine has often spoken and
written for general audiences on such matters as "the doctor
patient relation," AIDS, and scientific creativity.
Stuart Olmsted, Ph.D.,
received his doctoral degree in Biophysics from Johns Hopkins
University where he studied and tested reproductive technologies
including microbicides and contraceptives for the prevention of
sexually transmitted diseases, HIV and unwanted pregnancies. He
completed a postdoctoral fellowship at Magee-Womens Research
Institute in Pittsburgh before joining RAND, where he is currently
an Associate Natural Scientist. His research covers a wide range
of issues including military health care, health policy, public
health, and science and technology policy. Some of his recent
projects have involved the Army smallpox vaccination program,
future medical technologies for the Army and Navy, regional health
care initiatives, local bioterrorism response capabilities, and
the human genome project. Dr. Olmsted is also a former US Navy
submarine officer.
Kathie L. Olsen, Ph.D.,
Associate Director with the Office of Science and Technology
Policy (OSTP) in the Executive Office of the President serves as
OSTP Director Dr. John Marburger’s deputy for science and is
responsible for overseeing science and education policy, including
physical sciences, life sciences, environmental science, and
behavioral and social sciences. Prior to her confirmation, she
held the position of the Chief Scientist at the National
Aeronautics and Space Administration (NASA) (May 1999 - April
2002) and the Acting Associate Administrator for the new
Enterprise in Biological and Physical Research (July 2000-March
2002). Before joining NASA in May 1999, Olsen was the Senior
Staff Associate for the Science and Technology Centers in the
National Science Foundation (NSF) Office of Integrative
Activities. From February 1996 until November 1997, she was a
Brookings Institute Legislative Fellow and then an NSF detail in
the Office of Senator Conrad Burns of Montana. Preceding her work
on Capitol Hill, she served for two years as Acting Deputy
Director for the Division of Integrative Biology and Neuroscience
at the NSF, where she has worked and held numerous other
science-related positions. Dr. Olsen received her B.S. with honors
from Chatham College, Pittsburgh, Pa., majoring in both biology
and psychology and was elected to Phi Beta Kappa. She earned her
Ph.D. in Neuroscience at the University of California, Irvine. She
was a Postdoctoral Fellow in the Department of Neuroscience at
Children’s Hospital of Harvard Medical School. Subsequently at
SUNY-Stony Brook she was both a Research Scientist at Long Island
Research Institute and Assistant Professor in the Department of
Psychiatry and Behavioral Science at the Medical School. Her
research on neural and genetic mechanisms underlying development
and expression of behavior was supported by the National
Institutes of Health.
Alyson Reed, M.A.,
is the Executive Director of the National Postdoctoral
Association, providing staff leadership to this newly-formed
professional society representing postdoctoral scholars. Ms. Reed
is an experienced non-profit manager and executive, having
previously served as the Executive Director of the Maryland
Commission for Women and of the National Committee on Pay Equity.
She has also worked in senior management and policy posts at the
National Kidney Foundation and the American College of
Nurse-Midwives. Early in her career, Ms. Reed worked as a radio
news reporter for an NPR affiliate in upstate New York, and also
as a Project Manager for the League of Women Voters. In addition
to her professional experience, Ms. Reed earned a Masters degree
in Public Policy and Women’s Studies from the George Washington
University and a Bachelor’s degree in English Literature from SUNY-Binghamton.
She resides in University Park, Maryland.
Claudina A. Stevenson, Ph.D.,
is an Instructor in Medicine in the Dept. of Cancer Biology and
Director of the Office for Postdoctoral Training and Career
Development (OPTCD) at the Dana-Farber Cancer Institute. Her
research focuses on elucidating the role of ABC transporter drug
pumps in multidrug resistance. As Director of OPTCD, her
responsibilities include creating an environment to support and
prepare postdoc for successful careers. Dr. Stevenson obtained her
Ph.D. in Biochemistry and Molecular Biology from Louisiana State
University. She did her postdoctoral fellowship in the NCI Center
for Cancer Research. Dr. Stevenson is a founding member of the
National Postdoctoral Association.
Elsa S. Strotmeyer, Ph.D., M.P.H.,
was a founding member of the University of Pittsburgh Postdoctoral
Association (UPPDA) in 2002 and currently serves as Junior
Co-Chair. She is a Postdoctoral Associate in the Department of
Epidemiology at the University of Pittsburgh and was previously a
fellow on the NIA Aging Training Grant in the department. Her
research interests focus on how diabetes and glucose metabolism
impact the aging process, particularly through body composition,
bone health, and functional performance. She is a member of the
American Diabetes Association, the American Society of Bone and
Mineral Research, the Society for Epidemiologic Research, and the
National Postdoctoral Association. Dr. Strotmeyer received her
B.A. from Colgate University, where she graduated magna cum laude
and was elected to Phi Beta Kappa. After finishing her masters in
public health at the University of Pittsburgh, she stayed to
complete her PhD in epidemiology and was elected to Delta Omega,
the National Honor Society for Public Health. While a graduate
student, she served as Business Manager for the university-wide
Graduate and Professional Student Association and Treasurer for
the Student Government Association at the Graduate School of
Public Health. Dr. Strotmeyer was an instructor in the
Pennsylvania Governor’s School for Health Care as the Coordinator
of Core Courses and Learning Teams, the Public Health Course
Coordinator, and a Learning Team Consultant.
Steven K. Wendell, Ph.D.,
was elected to the Executive Board of the National Postdoctoral
Association (NPA) where he has also served as Chair of the Annual
Meeting Committee since 2003. Prior to his national service, Dr.
Wendell was one of the co-founders and elected senior co-chair of
the University of Pittsburgh Postdoctoral Association (UPPDA).
Dr. Wendell is a research associate at the University of
Pittsburgh in the department of Molecular Genetics and
Biochemistry where his research interest include the development
of Herpes Simplex Virus (HSV-1) vectors for use in manipulating
Embryonic Stem cells (ES). His graduate work was completed at the
University of Minnesota where he studied the role of ancient
endogenous retroviral elements on the evolutionarily conserved
alteration of gene expression.
|
